Option Care Health, Inc. (NASDAQ:OPCH) Stock Position Decreased by Voya Investment Management LLC

Voya Investment Management LLC cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 64.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 319,337 shares of the company’s stock after selling 584,198 shares during the period. Voya Investment Management LLC’s holdings in Option Care Health were worth $7,409,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health during the 4th quarter worth about $26,000. UMB Bank n.a. increased its position in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC increased its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after acquiring an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC raised its holdings in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares during the period. Finally, Sterling Capital Management LLC lifted its position in shares of Option Care Health by 638.5% in the 4th quarter. Sterling Capital Management LLC now owns 2,954 shares of the company’s stock valued at $69,000 after acquiring an additional 2,554 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

NASDAQ OPCH opened at $30.69 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.04 billion, a PE ratio of 25.79, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a 50 day moving average price of $33.34 and a two-hundred day moving average price of $28.79.

Analyst Ratings Changes

Several analysts have issued reports on OPCH shares. Barrington Research reissued an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research note on Monday, April 21st. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities reaffirmed a “market outperform” rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and upped their target price for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $33.75.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.64% of the stock is owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.